Mostrar el registro sencillo del ítem
dc.contributor.author
Lazic, Milos
dc.contributor.author
Inzaugarat, Maria Eugenia
dc.contributor.author
Povero, Davide
dc.contributor.author
Zhao, Iris C.
dc.contributor.author
Chen, Mark
dc.contributor.author
Nalbandian, Madlena
dc.contributor.author
Miller, Yury I.
dc.contributor.author
Cherñavsky, Alejandra Claudia
dc.contributor.author
Feldstein, Ariel E.
dc.contributor.author
Sears, Dorothy D.
dc.date.available
2017-06-21T21:55:10Z
dc.date.issued
2014-09
dc.identifier.citation
Lazic, Milos; Inzaugarat, Maria Eugenia; Povero, Davide; Zhao, Iris C.; Chen, Mark; et al.; Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis; Public Library of Science; Plos One; 9; 9; 9-2014; 1-11; e107658
dc.identifier.issn
1932-6203
dc.identifier.uri
http://hdl.handle.net/11336/18617
dc.description.abstract
Obesity is associated with metabolic perturbations including liver and adipose tissue inflammation, insulin resistance, and type 2 diabetes. Omega-6 fatty acids (ω6) promote and omega-3 fatty acids (ω3) reduce inflammation as they can be metabolized to pro- and anti-inflammatory eicosanoids, respectively. 12/15-lipoxygenase (12/15-LO) enzymatically produces some of these metabolites and is induced by high fat (HF) diet. We investigated the effects of altering dietary ω6/ω3 ratio and 12/15-LO deficiency on HF diet-induced tissue inflammation and insulin resistance. We examined how these conditions affect circulating concentrations of oxidized metabolites of ω6 arachidonic and linoleic acids and innate and adaptive immune system activity in the liver. For 15 weeks, wild-type (WT) mice were fed either a soybean oil-enriched HF diet with high dietary ω6/ω3 ratio (11∶1, HFH), similar to Western-style diet, or a fat Kcal-matched, fish oil-enriched HF diet with a low dietary ω6/ω3 ratio of 2.7∶1 (HFL). Importantly, the total saturated, monounsaturated and polyunsaturated fat content was matched in the two HF diets, which is unlike most published fish oil studies in mice. Despite modestly increased food intake, WT mice fed HFL were protected from HFH-diet induced steatohepatitis, evidenced by decreased hepatic mRNA expression of pro-inflammatory genes and genes involved in lymphocyte homing, and reduced deposition of hepatic triglyceride. Furthermore, oxidized metabolites of ω6 arachidonic acid were decreased in the plasma of WT HFL compared to WT HFH-fed mice. 12/15-LO knockout (KO) mice were also protected from HFH-induced fatty liver and elevated mRNA markers of inflammation and lymphocyte homing. 12/15-LOKO mice were protected from HFH-induced insulin resistance but reducing dietary ω6/ω3 ratio in WT mice did not ameliorate insulin resistance or adipose tissue inflammation. In conclusion, lowering dietary ω6/ω3 ratio in HF diet significantly reduces steatohepatitis.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Public Library of Science
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by/2.5/ar/
dc.subject
Omega 3
dc.subject
12/15 Lypoxigenase
dc.subject
Nafld
dc.subject
Immunity
dc.subject.classification
Inmunología
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2017-06-21T17:39:26Z
dc.journal.volume
9
dc.journal.number
9
dc.journal.pagination
1-11; e107658
dc.journal.pais
Estados Unidos
dc.journal.ciudad
San Francisco
dc.description.fil
Fil: Lazic, Milos. University of California at San Diego; Estados Unidos
dc.description.fil
Fil: Inzaugarat, Maria Eugenia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
dc.description.fil
Fil: Povero, Davide. University of California at San Diego; Estados Unidos
dc.description.fil
Fil: Zhao, Iris C.. University of California at San Diego; Estados Unidos
dc.description.fil
Fil: Chen, Mark. University of California at San Diego; Estados Unidos
dc.description.fil
Fil: Nalbandian, Madlena. University of California at San Diego; Estados Unidos
dc.description.fil
Fil: Miller, Yury I.. University of California at San Diego; Estados Unidos
dc.description.fil
Fil: Cherñavsky, Alejandra Claudia. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina
dc.description.fil
Fil: Feldstein, Ariel E.. University of California at San Diego; Estados Unidos
dc.description.fil
Fil: Sears, Dorothy D.. University of California at San Diego; Estados Unidos
dc.journal.title
Plos One
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1371/journal.pone.0107658
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0107658
Archivos asociados